Sodium Edecrin and Zoledronic Acid Injection Concentrate
Determining the interaction of Sodium Edecrin and Zoledronic Acid Injection Concentrate and the possibility of their joint administration.
In the database of official manuals used in the service creation an interaction registered by statistical results of studies was found, which can either lead to negative consequences for the patient health or strengthen a mutual positive effect. A doctor should be consulted to address the issue of joint drug administration.
Consumer:Using ethacrynic acid together with zoledronic acid may decrease the calcium levels in your blood. Contact your doctor if your condition changes or if you experience symptoms of hypocalcemia (low blood calcium) such as numbness or tingling around your mouth, uncontrolled muscle movements, irritability, depression, irregular heart beats, or any increased sensitivity. If your doctor does prescribe these medications together, you may need a dose adjustment or special tests to safely use both medications. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Professional:MONITOR: Coadministration of bisphosphonates and loop diuretics may potentiate the risk of hypocalcemia. Bisphosphonates alone often cause mild, asymptomatic hypocalcemia via inhibitive effects on bone resorption and possibly chelation of blood calcium. These effects may be additive with those of loop diuretics, which tend to increase the urinary excretion of calcium.
MANAGEMENT: Caution is advised if bisphosphonates are coadministered with loop diuretics. Renal function as well as serum calcium levels should be monitored during and after treatment, since the effects of bisphosphonates can continue for many weeks after discontinuation. Patients and clinicians should be alert to signs and symptoms of clinical hypocalcemia such as muscle spasm, carpopedal spasm, laryngeal spasm, tetany, convulsions, mental changes (irritability, depression, psychosis), increased intracranial pressure, papilledema, QT interval prolongation, and cardiac arrhythmias.
- "Product Information. Zometa (zoledronic acid)." Novartis Pharmaceuticals, East Hanover, NJ.
Generic Name: ethacrynic acid
Brand name: Sodium Edecrin, Edecrin, Edecrin Sodium
Synonyms: n.a.
Generic Name: zoledronic acid
Brand name: Reclast, Zometa, Zometa Concentrate, Aclasta
Synonyms: Zoledronic acid, Zoledronic Acid
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Sodium Edecrin-Zoledronic acid Intravenous
- Sodium Edecrin-Zoledronic Acid IV
- Sodium Edecrin-Zolgensma
- Sodium Edecrin-Zolinza
- Sodium Edecrin-Zolmitriptan
- Sodium Edecrin-Zolmitriptan nasal
- Zoledronic Acid Injection Concentrate-Sodium Ferric Gluconate
- Zoledronic Acid Injection Concentrate-Sodium ferric gluconate complex
- Zoledronic Acid Injection Concentrate-Sodium ferric gluconate complex Intravenous
- Zoledronic Acid Injection Concentrate-Sodium Glycerophosphate Pentahydrate
- Zoledronic Acid Injection Concentrate-Sodium hyaluronate injection
- Zoledronic Acid Injection Concentrate-Sodium Iodide